Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Boulder Peptide 2024Boulder Peptide 2024
Not Confirmed
Not Confirmed
16-19 September, 2024
Not Confirmed
Not Confirmed
17-19 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Boulder Peptide 2024Boulder Peptide 2024
Industry Trade Show
Not Confirmed
16-19 September, 2024
Industry Trade Show
Not Confirmed
17-19 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination
30 Aug 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/polaryx-therapeutics-announces-fda-grants-orphan-drug-designation-for-plx-200-in-gm2-gangliosidoses-301364861.html
11 Feb 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/polaryx-therapeutics-receives-both-rare-pediatric-disease-and-orphan-drug-designations-for-the-treatment-of-krabbe-disease-with-plx-300-301226528.html
10 Feb 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/polaryx-therapeutics-receives-both-rare-pediatric-disease-and-orphan-drug-designations-for-the-treatment-of-krabbe-disease-with-plx-300-301226528.html
18 Dec 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/polaryx-therapeutics-receives-both-rare-pediatric-disease-and-orphan-drug-designations-for-the-treatment-of-niemann-pick-disease-types-a-and-b-with-plx-300-301195771.html
18 Dec 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/polaryx-therapeutics-receives-both-rare-pediatric-disease-and-orphan-drug-designations-for-the-treatment-of-niemann-pick-disease-types-a-and-b-with-plx-300-301195771.html
25 Nov 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/polaryx-therapeutics-receives-both-rare-pediatric-disease-and-orphan-drug-designations-for-the-treatment-of-gm2-gangliosidosis-with-plx-300-301180296.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?